Analysis of prostate cancer: to take or not to take?

The farther, the more doubts expressed regarding the feasibility of conducting analyses for the presence of cancerous tumors of the prostate in men. Prostate cancer develops very slowly, and in a greater number of cases he will never threaten the patient’s life, which, according to the results of the analyses are beginning to treat aggressive and destructive to health drugs.

Biopsies aimed at detecting tumors of the prostate, can do a patient a disservice, experts believe. Detection in the early stages of prostate tumors is reason enough to start treatment to prolong the patient’s life, however, unlike other cancers, prostate cancer develops slowly and may not impact on the health of men for many years. Most men with prostate cancer die of other causes without even knowing about their disease. Because in the early stages it is impossible to determine whether the tumor is normal or very rare fast growing tumors, men diagnosed with prostate cancer is prescribed radiation therapy, surgery, hormonal treatment, etc. As a result, men who could live and function just like perfectly healthy people appear impotence and incontinence – the most common side effects of prostate cancer treatment.

Two major studies conducted in 2009 indicate that from tests for prostate cancer do more harm than good, many specialists are encouraged to refrain from screening.

Despite the fact that the Ministry of health does not recommend a test for the presence of prostate cancer in men older than 75 years, one-third goes to the survey. This is because men don’t give enough information about the value of tests and treatment side effects. “People should know that many of the analyses represent a double-edged sword” – say experts from the University of Texas, USA, stressing that the mass assignment tests should be replaced by a polling approach.

Leave a Reply